Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Bacteriophage genomics approach to antimicrobial drug discovery published in Nature Biotechnology

12.01.2004


Identifying the targets that bacterial viruses, or phages, use to halt bacterial growth and then screening against those targets for small molecule inhibitors that attack the same targets provides a unique platform for the discovery of novel antibiotics. Researchers from Montreal-based PhageTech, Inc. describe in the February issue of Nature Biotechnology this novel method for discovering new classes of antibiotics. The article is available on-line today at www.nature.com/nbt/.



"Over the course of evolution, the multitudes of phages that attack bacteria have developed unique proteins that bind to and inactivate (or redirect) critical cellular targets within their prey," said Jing Liu, Ph.D., corresponding author of the publication. "This binding shuts off key metabolic processes in the bacteria, diverting those organisms from their own growth and reproduction to the production of new phage progeny. We believe these phage-identified bacterial "weak spots" will provide useful screening targets for discovering the sorts of truly novel antibiotics needed to combat growing antibiotic resistance."

The publication’s authors used a high-throughput phage genomics strategy to identify novel 31 novel polypeptide families that inhibit Staphylococcus aureus growth when expressed in the bacteria. Several of these were found to attack targets essential for bacterial DNA replication or transcription. They then employed the interaction between a prototypic phage peptide, ORF104 of phage 77, and its bacterial target, DnaI, to screen for small molecule inhibitors. Using this strategy, the researchers found several novel compounds that inhibited both bacterial growth and DNA synthesis.


"This strategy offers several benefits as a novel approach to antimicrobial drug discovery," said Jinzi J. Wu, M.D., Ph.D., PhageTech vice president, R&D - biology. "First, the bacterial targets identified in this manner are evolutionarily validated as important to bacterial growth and potentially susceptible to inactivation by small molecule drugs. This allows us to quickly pinpoint the most promising anti-microbial targets from among thousands of possible candidates. Second, this approach provides a ready-to-use screening assay based on inhibition of interactions between a phage peptide and its bacterial target."

"The fight against growing bacterial resistance requires new classes of antibiotics against novel targets. Our strategy of screening for compounds that address the same antibacterial targets attacked by phages is a very good way of identifying novel compounds against many different bacterial species," concluded Dr Wu.

Applying its novel antibiotic discovery platform, PhageTech has identified eight novel antimicrobial targets against which the company is screening chemical libraries and applying medicinal chemistry to further refine and evaluate those inhibitors. PhageTech has also continued to expand its phage genomics platform from Staphylococcus aureus to other bacterial pathogens including Streptococcus pneumoniae and Pseudomonas aeruginosa.


About PhageTech

PhageTech is a private, venture-backed biopharmaceutical company focused on the discovery and development of new classes of antibiotic drugs for novel antibacterial targets, based on its world-leading efforts in phage genomics. By unraveling the genetic code of phages, or bacterial viruses, PhageTech identified antimicrobial proteins used by the phages to kill or stop the growth of bacteria, as well as the specific bacterial targets with which those proteins interact. The company then screens these bacterial targets to identify novel small molecule drugs that attack the same targets to achieve bacterial growth inhibitory effects. PhageTech is headquartered in Montreal, Québec. For more information on PhageTech, please contact Michel Harpin, director of business development at 514-332-1008.

Contact:

Michel Harpin
Director, Business Development
PhageTech
514-332-1008
mharpin@phagetech.com

Joan Kureczka
Kureczka/Martin Associates
415-821-2413
Jkureczka@aol.com

Joan Kureczka | EurekAlert!
Further information:
http://www.nature.com/nbt/
http://www.phagetech.com

More articles from Life Sciences:

nachricht Molecular microscopy illuminates molecular motor motion
26.07.2017 | Penn State

nachricht New virus discovered in migratory bird in Rio Grande do Sul, Brazil
26.07.2017 | Fundação de Amparo à Pesquisa do Estado de São Paulo

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Carbon Nanotubes Turn Electrical Current into Light-emitting Quasi-particles

Strong light-matter coupling in these semiconducting tubes may hold the key to electrically pumped lasers

Light-matter quasi-particles can be generated electrically in semiconducting carbon nanotubes. Material scientists and physicists from Heidelberg University...

Im Focus: Flexible proximity sensor creates smart surfaces

Fraunhofer IPA has developed a proximity sensor made from silicone and carbon nanotubes (CNT) which detects objects and determines their position. The materials and printing process used mean that the sensor is extremely flexible, economical and can be used for large surfaces. Industry and research partners can use and further develop this innovation straight away.

At first glance, the proximity sensor appears to be nothing special: a thin, elastic layer of silicone onto which black square surfaces are printed, but these...

Im Focus: 3-D scanning with water

3-D shape acquisition using water displacement as the shape sensor for the reconstruction of complex objects

A global team of computer scientists and engineers have developed an innovative technique that more completely reconstructs challenging 3D objects. An ancient...

Im Focus: Manipulating Electron Spins Without Loss of Information

Physicists have developed a new technique that uses electrical voltages to control the electron spin on a chip. The newly-developed method provides protection from spin decay, meaning that the contained information can be maintained and transmitted over comparatively large distances, as has been demonstrated by a team from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute. The results have been published in Physical Review X.

For several years, researchers have been trying to use the spin of an electron to store and transmit information. The spin of each electron is always coupled...

Im Focus: The proton precisely weighted

What is the mass of a proton? Scientists from Germany and Japan successfully did an important step towards the most exact knowledge of this fundamental constant. By means of precision measurements on a single proton, they could improve the precision by a factor of three and also correct the existing value.

To determine the mass of a single proton still more accurate – a group of physicists led by Klaus Blaum and Sven Sturm of the Max Planck Institute for Nuclear...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

Closing the Sustainability Circle: Protection of Food with Biobased Materials

21.07.2017 | Event News

»We are bringing Additive Manufacturing to SMEs«

19.07.2017 | Event News

 
Latest News

CCNY physicists master unexplored electron property

26.07.2017 | Physics and Astronomy

Molecular microscopy illuminates molecular motor motion

26.07.2017 | Life Sciences

Large-Mouthed Fish Was Top Predator After Mass Extinction

26.07.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>